Cocrystal Pharma, Inc.
COCP- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001412486
In the last 90 days, Cocrystal Pharma, Inc. insiders filed 2 open-market purchases and 0 sales; 27 institutions reported holding it in 13F filings for Q2 2026, worth $1.17M in total; no superinvestor holds it.
13F holders, Q4 2024
Institutional positions in Cocrystal Pharma, Inc. as of Dec 31, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 24
- +4 vs. Q3 2024
- Shares held
- 711.4K
- −7.89K (−1.1%) vs. Q3 2024
- Total value
- $1.44M
- +$171.1K (+13.5%) vs. Q3 2024
- New holders
- 5
- 4 more added
- Sold out
- 1
- 5 more reduced
Compare with Q3 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting COCP on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 27 | $1.17M |
| Q1 2026 | 26 | $783.8K |
| Q4 2025 | 28 | $754.3K |
| Q3 2025 | 22 | $831.3K |
| Q2 2025 | 22 | $1.02M |
| Q1 2025 | 24 | $1.06M |
| Q4 2024 | 24 | $1.44M |
| Q3 2024 | 20 | $1.27M |
| Q2 2024 | 14 | $1.57M |
| Q1 2024 | 16 | $1.01M |
| Q4 2023 | 17 | $1.17M |
| Q3 2023 | 16 | $1.32M |
| Q2 2023 | 20 | $1.59M |
| Q1 2023 | 21 | $1.47M |
| Q4 2022 | 21 | $2.08M |
| Q3 2022 | 27 | $3.95M |
| Q2 2022 | 33 | $5.83M |
| Q1 2022 | 34 | $7.90M |
| Q4 2021 | 35 | $9.78M |
| Q3 2021 | 41 | $16.1M |
| Q2 2021 | 42 | $25.0M |
| Q1 2021 | 35 | $13.5M |
Institutions, Q4 2024
Shares, value and share of portfolio for each institution holding Cocrystal Pharma, Inc.; share changes are against Q3 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Royal Bank of Canada | 51 | $0 | 0.00% | 00.0% | Unchanged |
| Activest Wealth Management | 1 | $2 | 0.00% | 00.0% | Unchanged |
| Citigroup Inc | 3 | $6 | 0.00% | +3 | New |
| Wells Fargo & Company | 6 | $12 | 0.00% | +6 | New |
| SBI Securities Co., Ltd. | 33 | $67 | 0.00% | +33 | New |
| NVWM, LLC | 84 | $170 | 0.00% | 00.0% | Unchanged |
| MAI Capital Management | 237 | $479 | 0.00% | +237 | New |
| JPMorgan Chase & Co | 259 | $523 | 0.00% | −152−37.0% | Reduced |
| Clean Yield Group | 418 | $844 | 0.00% | 00.0% | Unchanged |
| Northwestern Mutual Wealth Management Co | 817 | $1.65K | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 830 | $1.68K | 0.00% | −1,913−69.7% | Reduced |
| UBS Group AG | 6,130 | $12.4K | 0.00% | +5,220+573.6% | Added |
| Bank of America Corp | 9,021 | $18.2K | 0.00% | −29−0.3% | Reduced |
| Velan Capital Investment Management LP | 10,000 | $20.2K | 0.02% | +10,000 | New |
| Susquehanna International Group, LLP | 12,127 | $24.5K | 0.00% | −25,673−67.9% | Reduced |
| Northern Trust Corp | 12,171 | $24.6K | 0.00% | 00.0% | Unchanged |
| Dimensional Fund Advisors LP | 15,015 | $30.3K | 0.00% | +923+6.5% | Added |
| Parallel Advisors, LLC | 15,228 | $30.8K | 0.00% | 00.0% | Unchanged |
| State Street Corp | 20,543 | $41.5K | 0.00% | 00.0% | Unchanged |
| Morgan Stanley | 64,346 | $130.0K | 0.00% | +5,046+8.5% | Added |
| Geode Capital Management, LLC | 68,890 | $139.2K | 0.00% | +2,630+4.0% | Added |
| BlackRock, Inc. | 73,746 | $149.0K | 0.00% | 00.0% | Unchanged |
| Renaissance Technologies LLC | 125,828 | $254.2K | 0.00% | −4,200−3.2% | Reduced |
| Vanguard Group Inc | 275,656 | $556.8K | 0.00% | 00.0% | Unchanged |
| Advisor Group Holdings, Inc. | 0 | $0 | 0.00% | −17−100.0% | Sold out |